Cholib
·
- Prescription status not stated
- Heart, blood pressure and circulation
- Active substance
- Fenofibrate;simvastatin
- Made by
- Viatris Healthcare Limited
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Cholib is indicated as adjunctive therapy to diet and exercise in high cardiovascular risk adult patients with mixed dyslipidaemia to reduce triglycerides and increase HDL C levels when LDL C levels are adequately controlled with the corresponding dose of simvastatin monotherapy.
From the official label · 2026-09-30 · European Medicines Agency
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Viatris Healthcare Limited |
|---|---|
| Active substance | Fenofibrate;simvastatin |
| Used in | Heart, blood pressure and circulation |
| Classification | C10BA04 · Heart, blood pressure and circulation |
| Authorised on | 2013-08-26 |
| Last updated by the regulator | 2026-08-06 |
| EMA product number | EMEA/H/C/002559 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).